Eleonora Gaetani and Team Map Global Prevalence of HHT Using Population Genomics
Gemelli Computational Biology and Bioinformatics Lab shared on LinkedIn:
”In a new study published by Journal of Thrombosis and Haemostasis (JTH), we applied a computational, population-scale genomics approach to re-estimate the genetic prevalence of Hereditary Hemorrhagic Telangiectasia (HHT).
We have systematically analyzed known and potentially (according to HHT-specific ACMG/AMP criteria) pathogenic variants in ENG and ACVRL1 across three large genomic resources (gnomAD, All of Us, and Regeneron Genetics Center–Million Exome) and found that the genetic prevalence of HHT is substantially higher than current clinical estimates, thereby highlighting how large-scale variant aggregation and standardized pathogenicity frameworks can uncover underrecognized rare disease burden.
Work by Eleonora Gaetani, Agnese Giovannetti, Luigi Di Martino, Niccolò Liorni, Viviana Caputo, Antonio Gasbarrini, Roberto Pola, Tommaso Mazza at Agostino Gemelli University Hospital Foundation IRCCS”
Title: Global Prevalence of Hereditary Hemorrhagic Telangiectasia-Associated Variants Estimated by Analysis of Large-Scale Genomic Databases
Authors: Eleonora Gaetani, Agnese Giovannetti, Luigi Di Martino, Niccolò Liorni, Viviana Caputo, Antonio Gasbarrini, Roberto Pola, Tommaso Mazza
Read the Full Article on Journal of Thrombosis and Haemostasis (JTH)

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning